Skip to content
Find Clinical Trials
Home » Find Clinical Trials » Evaluation of the clinical efficacy and safety of perindopril 10 mg/indapamide 2.5 mg/amlodipine 5 or 10 mg/bisoprolol 5 mg in single-pill combination after 8 weeks of treatment versus the free combination of perindopril 10 mg, indapamide 2.5 mg and amlodipine 5 or 10 mg in patients with uncontrolled essential hypertension. An international, multicentre, randomised, double-blind, 16-week study.

Evaluation of the clinical efficacy and safety of perindopril 10 mg/indapamide 2.5 mg/amlodipine 5 or 10 mg/bisoprolol 5 mg in single-pill combination after 8 weeks of treatment versus the free combination of perindopril 10 mg, indapamide 2.5 mg and amlodipine 5 or 10 mg in patients with uncontrolled essential hypertension. An international, multicentre, randomised, double-blind, 16-week study.

Share Print
Servier Protocol Code: CL3-05179-002 Sponsor: Institut de Recherches Internationales Servier (I.R.I.S) EudraCT Number: 2020-004891-16

Find a recruiting site

Name: Institut de Recherches Internationales Servier, Département des études cliniques
Phone number: +33 1 55 72 60 00
Interventions / Treatments
  • Hypertension
  • AMLODIPINE
  • BISOPROLOL
  • INDAPAMIDE
  • PERINDOPRIL
  • S05179
Other study id numbers
  • CL3-05179-002